Quantitative analysis of cytomegalovirus load using a real-time PCR assay
- 1 April 2000
- journal article
- Published by Wiley in Journal of Medical Virology
- Vol. 60 (4) , 455-462
- https://doi.org/10.1002/(sici)1096-9071(200004)60:4<455::aid-jmv14>3.0.co;2-q
Abstract
A novel real-time PCR assay system was developed to quantify the cytomegalovirus (CMV) genome load. The real-time PCR assay could detect from 6 to over 10(6) copies of CMV-DNA with a wide linear range. The virus load of immunocompromised patients with symptomatic CMV infections was quantified and compared to that of asymptomatic ones. In symptomatic patients, all 17 peripheral blood leukocytes were positive for CMV DNA, and its mean value was 10(3.3) copies/10(6) cells. On the other hand, only 9 of 38 samples (24%) were positive in the asymptomatic patients, and its mean titer was lower (10(2.0) copies/10(6) cells) than that of the symptomatic group (P = 0.002). In plasma, the virus genome was detected in 13 out of 17 samples from symptomatic patients (76%), and its mean value was 10(4.0) copies/ml. In contrast, for the asymptomatic group, only one out of 36 samples were positive (3%). Finally, this system was used to monitor two patients with CMV infections serially. The CMV DNA copy number changed with their clinical symptoms and anti-CMV therapy, and virtually paralleled the result of the pp65 antigenemia assay in both cases. In one patient with the cord blood transplantation, however, the CMV DNA became positive faster than the antigenemia assay. These results indicate that this assay is sensitive and useful for estimating the CMV genome load not only in peripheral blood leukocytes but also in plasma. It can be very helpful for diagnosing CMV-related diseases and monitoring the virus load in patients with CMV infections.Keywords
This publication has 29 references indexed in Scilit:
- Identification of HHV8 in early Kaposi's sarcoma: implications for Kaposi's sarcoma pathogenesisMolecular Pathology, 1998
- Management of Cytomegalovirus Infection after Solid-Organ or Stem-Cell TransplantationDrugs, 1998
- PLASMA POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATIONTransplantation, 1997
- Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infectionAntiviral Research, 1996
- Real time quantitative PCR.Genome Research, 1996
- CLINICAL AND VIROLOGICAL MONITORING OF HUMAN CYTOMEGALOVTRUS INFECTION IN 294 HEART TRANSPLANT RECIPIENTSTransplantation, 1995
- Quantitation of Human Cytomegalovirus (HCMV) DNA in Cerebrospinal Fluid by Competitive PCR in AIDS Patients with Different HCMV Central Nervous System DiseasesScandinavian Journal of Infectious Diseases, 1995
- Quantitative analysis of herpes simplex virus DNA in cerebrospinal fluid of children with herpes simplex encephalitisJournal of Medical Virology, 1993
- Monitoring of Human Cytomegalovirus Infections and Ganciclovir Treatment in Heart Transplant Recipients by Determination of Viremia, Antigenemia, and DNAemiaThe Journal of Infectious Diseases, 1991
- The structure of the major immediate early gene of human cytomegalovirus strain AD169Virus Research, 1985